These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31546735)

  • 1. Knockdown of RhoE Expression Enhances TGF-β-Induced EMT (epithelial-to-mesenchymal transition) in Cervical Cancer HeLa Cells.
    Nishizuka M; Komada R; Imagawa M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells.
    Goto M; Osada S; Imagawa M; Nishizuka M
    Sci Rep; 2017 Nov; 7(1):16365. PubMed ID: 29180690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200b inhibits epithelial-mesenchymal transition and migration of cervical cancer cells by directly targeting RhoE.
    Cheng YX; Chen GT; Chen C; Zhang QF; Pan F; Hu M; Li BS
    Mol Med Rep; 2016 Apr; 13(4):3139-46. PubMed ID: 26935796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β.
    Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C
    J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
    PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway.
    Fan Q; Qiu MT; Zhu Z; Zhou JH; Chen L; Zhou Y; Gu W; Wang LH; Li ZN; Xu Y; Cheng WW; Wu D; Bao W
    Oncol Rep; 2015 Oct; 34(4):1787-94. PubMed ID: 26239019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia.
    Zhou J; Li K; Gu Y; Feng B; Ren G; Zhang L; Wang Y; Nie Y; Fan D
    Biochem Biophys Res Commun; 2011 Nov; 415(2):348-54. PubMed ID: 22037464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of small GTPases of the Rho/Rac family in TGF-β-induced EMT and cell motility in cancer.
    Ungefroren H; Witte D; Lehnert H
    Dev Dyn; 2018 Mar; 247(3):451-461. PubMed ID: 28390160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
    Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
    Sommerova L; Ondrouskova E; Vojtesek B; Hrstka R
    BMC Cancer; 2017 Aug; 17(1):546. PubMed ID: 28810836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer.
    Yoriki K; Mori T; Kokabu T; Matsushima H; Umemura S; Tarumi Y; Kitawaki J
    Sci Rep; 2019 Apr; 9(1):6697. PubMed ID: 31040369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF-β signaling.
    Kaowinn S; Kim J; Lee J; Shin DH; Kang CD; Kim DK; Lee S; Kang MK; Koh SS; Kim SJ; Chung YH
    Oncotarget; 2017 Jan; 8(3):5092-5110. PubMed ID: 27974707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
    Juang YL; Jeng YM; Chen CL; Lien HC
    Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
    Sengupta S; Jana S; Bhattacharyya A
    Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.